AstraZeneca PLC’s Nasal Flu Vaccine, Fluenz Gets European Medicines Evaluation Agency’s Backing For Kids

October 22, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, Oct 22 (Reuters) - AstraZeneca's (AZN.L) nasal flu vaccine has been recommended for approval in Europe, initially for children, although it is unlikely to go on sale until 2012.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Europe

AstraZeneca